These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 18095234)

  • 41. Controlling type-2 diabetes by inclusion of Cr-enriched yeast bread in the daily dietary pattern: a randomized clinical trial.
    Yanni AE; Stamataki NS; Konstantopoulos P; Stoupaki M; Abeliatis A; Nikolakea I; Perrea D; Karathanos VT; Tentolouris N
    Eur J Nutr; 2018 Feb; 57(1):259-267. PubMed ID: 27734127
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Add-on treatment with teneligliptin ameliorates glucose fluctuations and improves glycemic control index in Japanese patients with type 2 diabetes on insulin therapy.
    Tanaka S; Suzuki K; Aoki C; Niitani M; Kato K; Tomotsune T; Aso Y
    Diabetes Technol Ther; 2014 Dec; 16(12):840-5. PubMed ID: 25144424
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antithrombotic effects of rosiglitazone-metformin versus glimepiride-metformin combination therapy in patients with type 2 diabetes mellitus and metabolic syndrome.
    Derosa G; Gaddi AV; Piccinni MN; Ciccarelli L; Salvadeo S; Peros E; Ghelfi M; Ferrari I; Cicero AF
    Pharmacotherapy; 2005 May; 25(5):637-45. PubMed ID: 15899724
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effectiveness and Safety of Physician-Led Versus Patient-Led Titration of Insulin Glargine in Indian Patients with Type 2 Diabetes Mellitus: A Subanalysis of the Asian Treat to Target Lantus Study (ATLAS).
    Misra A; Patel M; Agarwal P; Lodha S; Tandon N; Magdum M; Yajnik C; Ghosh R; Walekar A
    Diabetes Technol Ther; 2019 Nov; 21(11):656-664. PubMed ID: 31335198
    [No Abstract]   [Full Text] [Related]  

  • 45. Rosiglitazone reduces insulin requirement and C-reactive protein levels in type 2 diabetic patients receiving peritoneal dialysis.
    Wong TY; Szeto CC; Chow KM; Leung CB; Lam CW; Li PK
    Am J Kidney Dis; 2005 Oct; 46(4):713-9. PubMed ID: 16183427
    [TBL] [Abstract][Full Text] [Related]  

  • 46. United Kingdom Prospective Diabetes Study 17: a 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus.
    Turner R; Cull C; Holman R
    Ann Intern Med; 1996 Jan; 124(1 Pt 2):136-45. PubMed ID: 8554206
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of rosiglitazone on beta-cell function, insulin resistance, and adiponectin concentrations: results from a double-blind oral combination study with glimepiride.
    Pfützner A; Schöndorf T; Seidel D; Winkler K; Matthaei S; Hamann A; Forst T
    Metabolism; 2006 Jan; 55(1):20-5. PubMed ID: 16324915
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Re-examining insulin compared to non-insulin therapies for type 2 diabetes: when in the disease trajectory is insulin preferable?
    Mishriky BM; Cummings DM; Tanenberg R; Pories WJ
    Postgrad Med; 2018 Nov; 130(8):653-659. PubMed ID: 30301398
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pilot study to evaluate the effect of short-term improvement in vitamin D status on glucose tolerance in patients with type 2 diabetes mellitus.
    Parekh D; Sarathi V; Shivane VK; Bandgar TR; Menon PS; Shah NS
    Endocr Pract; 2010; 16(4):600-8. PubMed ID: 20350923
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Athrixia phylicoides tea infusion (bushman tea) improves adipokine balance, glucose homeostasis and lipid parameters in a diet-induced metabolic syndrome rat model.
    Mokwena MAM; Engwa GA; Nkeh-Chungag BN; Sewani-Rusike CR
    BMC Complement Med Ther; 2021 Nov; 21(1):292. PubMed ID: 34844584
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inflammatory cytokines, adiponectin, insulin resistance and metabolic control after periodontal intervention in patients with type 2 diabetes and chronic periodontitis.
    Sun WL; Chen LL; Zhang SZ; Wu YM; Ren YZ; Qin GM
    Intern Med; 2011; 50(15):1569-74. PubMed ID: 21804283
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Response to intensive therapy steps and to glipizide dose in combination with insulin in type 2 diabetes. VA feasibility study on glycemic control and complications (VA CSDM).
    Abraira C; Henderson WG; Colwell JA; Nuttall FQ; Comstock JP; Emanuele NV; Levin SR; Sawin CT; Silbert CK
    Diabetes Care; 1998 Apr; 21(4):574-9. PubMed ID: 9571345
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Short- and Long-Term Effects of Wholegrain Oat Intake on Weight Management and Glucolipid Metabolism in Overweight Type-2 Diabetics: A Randomized Control Trial.
    Li X; Cai X; Ma X; Jing L; Gu J; Bao L; Li J; Xu M; Zhang Z; Li Y
    Nutrients; 2016 Sep; 8(9):. PubMed ID: 27618090
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Can a tool that automates insulin titration be a key to diabetes management?
    Bergenstal RM; Bashan E; McShane M; Johnson M; Hodish I
    Diabetes Technol Ther; 2012 Aug; 14(8):675-82. PubMed ID: 22568777
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of metformin and rosiglitazone combination therapy in patients with type 2 diabetes mellitus: a randomized controlled trial.
    Fonseca V; Rosenstock J; Patwardhan R; Salzman A
    JAMA; 2000 Apr; 283(13):1695-702. PubMed ID: 10755495
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The ratio of leptin to adiponectin can be used as an index of insulin resistance.
    Oda N; Imamura S; Fujita T; Uchida Y; Inagaki K; Kakizawa H; Hayakawa N; Suzuki A; Takeda J; Horikawa Y; Itoh M
    Metabolism; 2008 Feb; 57(2):268-73. PubMed ID: 18191059
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A 16-week open-label, multicenter pilot study assessing insulin pump therapy in patients with type 2 diabetes suboptimally controlled with multiple daily injections.
    Frias JP; Bode BW; Bailey TS; Kipnes MS; Brunelle R; Edelman SV
    J Diabetes Sci Technol; 2011 Jul; 5(4):887-93. PubMed ID: 21880230
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Improvements in glucose metabolism and insulin sensitivity with a low-carbohydrate diet in obese patients with type 2 diabetes.
    Krebs JD; Bell D; Hall R; Parry-Strong A; Docherty PD; Clarke K; Chase JG
    J Am Coll Nutr; 2013; 32(1):11-7. PubMed ID: 24015695
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of add-on treatment with sitagliptin on narrowing the range of glucose fluctuations in Japanese type 2 diabetes patients receiving insulin therapy.
    Mori Y; Taniguchi Y; Miyazaki S; Yokoyama J; Utsunomiya K
    Diabetes Technol Ther; 2013 Mar; 15(3):237-40. PubMed ID: 23402316
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-term efficacy of dapagliflozin in patients with type 2 diabetes mellitus receiving high doses of insulin: a randomized trial.
    Wilding JP; Woo V; Soler NG; Pahor A; Sugg J; Rohwedder K; Parikh S;
    Ann Intern Med; 2012 Mar; 156(6):405-15. PubMed ID: 22431673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.